U.S. Electrical Stock News

NasdaqGS:GFS
NasdaqGS:GFSSemiconductor

Assessing GlobalFoundries (GFS) Valuation After New U.S. Patent Lawsuits Against Tower Semiconductor

GLOBALFOUNDRIES (GFS) has moved into the spotlight after filing multiple U.S. patent infringement lawsuits against Tower Semiconductor, a legal step that puts its manufacturing know how and intellectual property protections front and center for investors. See our latest analysis for GLOBALFOUNDRIES. The legal action lands at a time when the share price is US$42.94, with a 19.78% 90 day share price return and a 16.40% 1 year total shareholder return, contrasting with a 3 year total shareholder...
NYSE:CACI
NYSE:CACIProfessional Services

Is It Time To Reassess CACI International (CACI) After The Recent Share Price Pullback

For investors wondering if CACI International at around US$563 per share still offers value after a strong run, this article explains what the current price may be implying about the stock. The share price is US$563.67 after a 7% decline over the last week and a 7.6% decline over the last month. Despite this, the 1 year return is 51%, and the 3 year and 5 year returns are 90.2% and 126.7% respectively. Recent coverage has focused on the stock's strong multi year performance and the pullback...
NasdaqGM:WRD
NasdaqGM:WRDAuto Components

WeRide Buyback Links Slovakia Expansion And NVIDIA GTC Spotlight To Valuation

WeRide, listed as NasdaqGM:WRD, has launched a share repurchase program covering up to 10% of its issued share capital. In addition, the buyback follows the company’s recent entry into Slovakia to roll out what it calls the country’s first autonomous vehicle initiative. WeRide also presented its next generation Robotaxi at NVIDIA GTC 2026, highlighting its technical partnership and product roadmap. For anyone tracking autonomous driving, WeRide sits at the intersection of software, hardware...
NYSE:CXT
NYSE:CXTElectronic

Has Crane NXT (CXT) Fallen Too Far After Recent Share Price Weakness?

If you are wondering whether Crane NXT is attractively priced or just a value trap, starting with a clear view of its recent share performance and fundamentals can help frame the question. The stock last closed at US$41.15, with a 1.9% gain over the past week, a 14.8% decline over the past month, a 13.8% decline year to date, and a 18.8% decline over the last year. Its 3 year return sits at 9.4%. Recent coverage has focused on providing evergreen context for Crane NXT, aiming to keep...
NYSE:AB
NYSE:ABCapital Markets

Is AllianceBernstein (AB) Fairly Priced After Recent Share Price Declines?

Wondering whether AllianceBernstein Holding at around US$35.66 is priced attractively, too expensive, or somewhere in between? This article walks through the key signals that matter for you as a shareholder or potential investor. The stock has seen mixed returns, with a 3.9% decline over the past week, a 9.2% decline over the last 30 days, a 7.7% decline year to date, but a 1.0% return over 1 year and gains of 26.7% over 3 years and 31.8% over 5 years. These moves have come as investors...
NYSE:SCCO
NYSE:SCCOMetals and Mining

Is It Too Late To Consider Southern Copper (SCCO) After The Recent 25.8% Pullback?

Wondering whether Southern Copper at around US$162 a share still makes sense for your portfolio, or if the easy gains are already behind it. The stock has returned 6.1% over the last 7 days, while the 30 day return sits at a 25.8% decline and the 1 year return stands at 83.6%, with longer 3 and 5 year returns of 149.7% and 208.1%. Recent market attention has focused on Southern Copper as part of a broader interest in large copper producers and their role in supply for global industry. That...
NasdaqGS:ROIV
NasdaqGS:ROIVBiotechs

Assessing Roivant Sciences (ROIV) Valuation After Brepocitinib Priority Review And Phase 3 VALOR Success

Why the brepocitinib data matters for Roivant Sciences (ROIV) The Phase 3 VALOR trial results for brepocitinib in dermatomyositis, published in the New England Journal of Medicine and paired with an FDA Priority Review, put a key Roivant Sciences (ROIV) asset firmly in focus for investors. See our latest analysis for Roivant Sciences. Roivant’s recent brepocitinib milestones arrive after a 1 year total shareholder return of 155.49% and a 3 year total shareholder return of 259.35%. The share...
NYSE:THR
NYSE:THRElectrical

Thermon And CECO Deal Recasts Growth, Recurring Revenue And 3D Focus

CECO and Thermon Group Holdings (NYSE:THR) announced a planned combination that management describes as a scale play with commercial synergies. The transaction is framed around Thermon's 3D strategy of decarbonization, digitalization, and diversification, as well as a shift toward more recurring revenue. Leadership highlights expectations for double-digit growth, improved EBITDA margins, and near term cross selling opportunities across the combined customer base. Thermon, known for...
NasdaqCM:PCT
NasdaqCM:PCTChemicals

PureCycle Technologies (PCT) Valuation Check After €40 Million EU Grant For ASTRA PP Project

PureCycle Technologies (PCT) has signed a €40 million grant agreement with the European Innovation Fund to support its ASTRA PP polypropylene recycling facility at the Port of Antwerp Bruges, marking a significant operational milestone in Europe. See our latest analysis for PureCycle Technologies. Despite securing the €40 million EU grant for ASTRA PP, PureCycle’s share price return has been weak, with a 30 day share price return of 16.32% and a 1 year total shareholder return of 24.79%. This...
NasdaqGS:ZION
NasdaqGS:ZIONBanks

Zions Shareholder Vote On Values Proposal Meets Undervalued Share Price Story

Zions Bancorporation National Association urged shareholders to vote against a proposal raised by The Heritage Foundation. The proposal focuses on aligning company policies with customer values and related risk. The vote is scheduled for the upcoming annual shareholders meeting. For investors watching NasdaqGS:ZION, this shareholder proposal puts corporate governance and risk oversight in the spotlight. The company last closed at $55.4, with a value score of 5 and a 1 year return of 15.7%...
NYSE:CRBG
NYSE:CRBGDiversified Financial

Corebridge And Equitable Merger Sparks Questions On Valuation Discount

Corebridge Financial (NYSE:CRBG) has agreed to merge with Equitable Holdings in an all stock transaction. The combined company is expected to become a major provider across retirement, life insurance, wealth, and asset management, serving over 12 million customers. The deal is described by both companies as transformational for their insurance and financial services franchises. For investors watching NYSE:CRBG, the merger news arrives after a challenging stretch for the stock. Shares...
NYSE:WLY
NYSE:WLYMedia

How Wiley’s Higher Dividend and Bigger Buyback Plan Will Impact John Wiley & Sons (WLY) Investors

John Wiley & Sons recently declared a quarterly cash dividend of US$0.355 per share on its Class A and Class B common stock, payable on April 23, 2026, to shareholders of record on April 7, 2026. This dividend increase to an annualized US$1.42 per share, alongside an expanded US$100 million share repurchase allocation for Fiscal 2026, highlights Wiley’s continued emphasis on returning capital to shareholders over time. We’ll now explore how Wiley’s higher dividend and larger share repurchase...
NasdaqGS:TSLA
NasdaqGS:TSLAAuto

Tesla Autonomy Probe Tests Valuation And Full Self Driving Promise

Federal regulators have opened a probe into Tesla's camera-only autonomous driving system, focusing on performance in low-visibility conditions. The investigation could lead to a requirement for new hardware on millions of Tesla vehicles already on the road. The review targets the core technology behind Tesla's Full Self-Driving ambitions and potential robotaxi and robotics offerings. Tesla, traded as NasdaqGS:TSLA, enters this investigation with its shares at $361.83 and a return of 37.3%...
NasdaqGS:NVDA
NasdaqGS:NVDASemiconductor

Is It Too Late To Consider Nvidia (NVDA) After Recent Share Price Pullback?

Wondering if NVIDIA's current share price still makes sense after years of strong returns, or if you might be overpaying for growth that is already in the story. The stock last closed at US$167.52, with a 3.0% decline over the past week and a 5.5% decline over the past month, even though the 1 year return is 52.8% and the 3 year return is very large. Recent coverage has focused on NVIDIA's role at the center of AI computing and the heavy demand for its chips across data centers and advanced...
NYSE:GVA
NYSE:GVAConstruction

What Granite Construction (GVA)'s US$495 Million Laredo Border Project Win Means For Shareholders

Granite Construction announced that it has been awarded the LRT-4 Webb-Zapata border infrastructure project by U.S. Customs and Border Protection, a roughly US$495 million contract covering 27 miles of roads, bridges, fencing, and advanced electrical and fiberoptic systems near Laredo, Texas, which was added to its first quarter 2026 committed and awarded projects. The project’s scale, complexity, and multi-year timeline through July 2027 highlight Granite’s role in large federally funded...
NYSE:ABT
NYSE:ABTMedical Equipment

Is Abbott Laboratories (ABT) Offering Value After Recent Share Price Weakness?

Wondering if Abbott Laboratories at around US$103.99 is priced for opportunity or risk? This article focuses squarely on what the current share price might be implying about value. The stock has recently been under pressure, with a 1.4% decline over the last 7 days, a 10.6% decline over 30 days, a 16.3% decline year to date, and a 19.0% decline over the past year, while the 3 year return sits at 8.9% and the 5 year return at a 4.2% decline. Recent market discussion has focused on Abbott...
NasdaqGS:FTAI
NasdaqGS:FTAIAerospace & Defense

Is It Too Late To Consider FTAI Aviation (FTAI) After Its Recent Share Price Surge

For readers wondering whether FTAI Aviation's current share price still offers value, or if most of the opportunity is already priced in, this article walks through what the numbers actually say. The stock recently closed at US$239.06, with returns of 3.9% over 7 days, a 21.8% decline over 30 days, 13.6% year to date, 114.6% over 1 year, and a very large gain over 3 years that is roughly 8x, as well as an even larger gain over 5 years. Recent coverage has focused on FTAI Aviation's position...
NYSE:YUM
NYSE:YUMHospitality

Is Yum Brands (YUM) Fairly Priced After Recent Share Price Pullback

Wondering if Yum! Brands at around US$153.96 is still a fair deal or starting to look stretched? This article walks through what the current price might actually be implying. The stock is up 2.3% year to date and 0.7% over the past year, although the share price has seen an 8.4% pullback over 30 days and a 1.6% slip over the last week, which may have changed how the market is thinking about risk and reward. Recent attention around Yum! Brands has focused on its position as a major global...
NasdaqGS:AMKR
NasdaqGS:AMKRSemiconductor

A Look At Amkor Technology (AMKR) Valuation After Mixed Short Term Share Price Moves

Event context and recent share performance Amkor Technology (AMKR) has drawn investor attention after recent share price moves, with the stock down about 7% over the past month but up roughly 11% in the past 3 months. See our latest analysis for Amkor Technology. At a share price of $44.45, Amkor’s recent 7% 1 month share price decline contrasts with a stronger 10.9% 3 month share price return and very large 1 year total shareholder return. This suggests that earlier momentum is cooling in...
NYSE:PBI
NYSE:PBICommercial Services

Assessing Pitney Bowes (PBI) Valuation After Recent Share Price Momentum And Analyst Upside Estimates

What recent performance says about Pitney Bowes (PBI) Pitney Bowes (PBI) has drawn investor attention after a period where the stock showed mixed short term moves, including a 1 day decline of 0.7% and gains over the past week and year. See our latest analysis for Pitney Bowes. The recent 6.7% 7 day share price return, alongside a 5.2% year to date share price gain and a 214% three year total shareholder return, points to momentum that has been building rather than fading. If Pitney Bowes has...
NYSE:REX
NYSE:REXOil and Gas

Why REX American Resources (REX) Is Up 23.3% After Record 2025 Earnings Powered By 45Z Tax Credits

REX American Resources reported past fourth-quarter 2025 sales of US$157.96 million, with net income rising to US$43.75 million, and full-year 2025 sales of US$650.49 million alongside net income of US$82.95 million. Record earnings per share, record ethanol sales volumes, substantial US$28.00 million in 45Z tax credits, and progress on capacity expansion and carbon capture projects collectively reshaped the company’s earnings mix and growth profile. We’ll now examine how record 2025...
NYSE:WELL
NYSE:WELLHealth Care REITs

Assessing Welltower (WELL) Valuation After A Strong Multi‑Year Shareholder Return Run

What stands out about Welltower right now Welltower (WELL) sits at the center of what it calls the silver economy, with a portfolio of more than 2,000 seniors and wellness housing communities across the United States, United Kingdom and Canada. At a recent share price of US$195.77 and a market value of about US$136.6b, the company reports annual revenue of US$10.84b and net income of US$936.85m, primarily from seniors housing operating assets. See our latest analysis for Welltower. Recent...